Sponsorship Benefits
ESGO 2025 is the landmark event in the field of gynaecological cancers, don't miss out on your opportunity to join us in Rome to:
- Showcase your role in the field to an audience of over 2500 global participants
- Promote your products to world experts and professionals in gynaecological oncology, oncology and related professions
- Be associated with innovative educational opportunities connecting world experts and delegates
- Open up or build on new markets and networking opportunities with world leading influencers and decision makers
MedTech Application
EthicalMedTech is a unique platform supported by MedTech Europe and dedicated to ethics and compliance projects in the healthcare sector. It is hosting major industry compliance initiatives – including EFPIA’s evaluation platform for European medical conferences
ESGO 2025 has submitted the application EMT-24-00823 and is currently under Full Review.
AIFA Application
The Italian Medicines Agency - AIFA is a public body operating according to the principles of autonomy, transparency and efficiency, under the direction of the Ministry of Health and the supervision of the Ministry of Health and the Ministry of Economy.
AIFA is the national public body that regulates medicines for human use in Italy. AIFA governs pharmaceutical expenditure and follows the life cycle of the medicine to ensure its effectiveness, safety and appropriateness as well as access to the national territory. Specifically, AIFA manages the authorisation processes for clinical trials, the manufacturing of medicines and active substances as well as inspection and pharmacovigilance activities.
ESGO 2025 has submitted the application 10446 and is currently under review.
Any Questions?
To find out more about
ESGO 2025 sponsorship and exhibition opportunities,
please contact: Zuzana Seps, Director of Congress and Educational Events
Tel: +420 725 537 730
Email: zuzana.seps@esgo.org
Message for Italian Pharma Companies (for AIFA application)
In Italy each pharmaceutical company sponsor in a meeting or in a congress on topics related to the use of their own pharmaceutical products, must submit to the competent Unit of the Italian Medicines Agency (AIFA) their application to obtain a specific authorization.
This is in respect of an Italian Government Decree (Decreto Legislativo 219/06 art. 124).
The request of authorisation is to be prepared well in advance and must be submitted in AIFA within 60 days that precede the starting date of the event.
In compliance with the given instructions please contact for the AIFA application documents:
Irene Signorini
E-Mail: i.signorini@thetriumph.com
Triumph Italy Srl
Via Belfiore 9, 50144 Firenze, Italy